Home▸Ketamine/Esketamine Therapy▸Ketamine Dissociative Side Effect Monitoring Simulator

💉 Ketamine Dissociative Side Effect Monitoring Simulator

This simulation focuses on monitoring dissociative side effects during and after a ketamine infusion. It uses the CADSS (Clinical Assessment of Dissociation Scale) to assess patient symptoms and ensure safe administration.

Ketamine/Esketamine Therapy2DModerate60 FPS
ketamine-dissociative-monitoring-simulator ↗ Open standalone

Establishing a Pre-Infusion CADSS Baseline

A short placeholder sentence on baseline dissociation scoring.

  • 0–92: Scale range (Placeholder CADSS total range)
  • 23: Items assessed (Placeholder item count)
  • 0–2: Typical baseline (Placeholder normal score)
  • ~3 min: Assessment time (Placeholder duration)

Why a baseline CADSS matters

Placeholder: baseline score anchors later comparisons during infusion.

Who administers the scale

Placeholder: clinician or nurse rates patient before drug starts.

Onset of Dissociative Symptoms During Infusion

A short placeholder sentence on early dissociation onset.

  • 5–15 min: Onset window (Placeholder onset timing)
  • Derealization: First symptoms (Placeholder early sign)
  • ~10–25: CADSS at onset (Placeholder score range)
  • Every 5 min: Check frequency (Placeholder monitoring cadence)

Early perceptual changes

Placeholder: mild unreality and detachment reported by patient.

Vital sign correlation

Placeholder: heart rate and blood pressure tracked alongside CADSS.

Peak Dissociative Symptoms Mid-Infusion

A short placeholder sentence on peak dissociation severity.

  • 20–35 min: Peak timing (Placeholder peak window)
  • ~40–70: Peak CADSS (Placeholder peak score)
  • Depersonalization: Common symptom (Placeholder dominant symptom)
  • CADSS >45: Action threshold (Placeholder alert level)

Peak symptom pattern

Placeholder: perceptual distortion and detachment reach maximum intensity.

When to intervene

Placeholder: high scores may prompt infusion rate adjustment.

Post-Infusion Recovery and Symptom Resolution

A short placeholder sentence on post-infusion decline.

  • At 40 min: Recovery start (Placeholder infusion end)
  • ~15–20 min: Half-resolution (Placeholder decay time)
  • Near 0: CADSS by 90 min (Placeholder resolved score)
  • CADSS <4: Discharge check (Placeholder discharge criterion)

Symptom decay curve

Placeholder: dissociation fades exponentially after infusion stops.

Discharge readiness

Placeholder: patient cleared once CADSS returns near baseline.

Interpreting CADSS Totals for Monitoring Decisions

A short placeholder sentence on reading CADSS thresholds.

  • 0–3: None (Placeholder routine tier)
  • 4–19: Mild (Placeholder watch tier)
  • 20–44: Moderate (Placeholder notify tier)
  • 45+: Severe (Placeholder intervene tier)

Threshold-based action tiers

Placeholder: score bands map to specific monitoring responses.

Documenting outcomes

Placeholder: record peak CADSS and actions taken per session.

⚙ Under the hood

This simulation focuses on monitoring dissociative side effects during and after a ketamine infusion. It uses the CADSS (Clinical Assessment of Dissociation Scale) to assess patient symptoms and ensure safe administration.

CanvasBiomedicine

2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install

What did you find?

Add reproduction steps (optional)